Late additionSecondary
SK Capital Partners, Bain Capital Life Sciences acquire Swixx Biopharma
SourcingClub was not involved in this transaction.
Mérieux Equity Partners has completed the sale of a majority of its shares in Swixx Biopharma to SK Capital Partners and Bain Capital Life Sciences. Swixx Biopharma was a portfolio company of Mérieux Participations 4.
Deal-Radar editorial team · responsible: Nick Herbig
late addition, source dated 02 Jun 2026: merieux-partners.com
How the deal fits together.
- Mérieux Equity Partners (Mérieux Participations 4)Seller
Target: Swixx Biopharma
Buyer: SK Capital Partners, Bain Capital Life Sciences
Who was involved.
- Target
- Swixx Biopharma
- Seller
- Mérieux Equity Partners (Mérieux Participations 4)
- Type
- Secondary
- Country
Switzerland
- Source dated
- 02/06/2026
- Source
- merieux-partners.com
Deal-Radar no. 47-208 · added in Week 47/2026, first reported on 02/06/2026 · publicly reported, no guarantee · SourcingClub was not involved in this transaction. Report an error · Sources and limits
We report publicly announced information and link the source; we accept no liability for its accuracy. No offer and no investment, legal or tax advice. The operators of linked pages are responsible for their content. We correct errors as soon as we learn of them.
June 2026 on the Deal-Radar.
4 of 21 deals were of the type Secondary.
- Buy-out8
- Add-on4
- Secondary4
- Strategic4
- Carve-out1
New deals every day. By email on Mondays.
All deals of the previous week in one email, with source and adviser.



